Update of Survival for Persons With HIV Infection in Denmark
Authors: Nicolai Lohse, Niels Obel
Journal: Annals of Internal Medicine (2016)

Letters15 November 2016Update of Survival for Persons With HIV Infection in DenmarkNicolai Lohse, MD, PhD, DMSc and Niels Obel, MD, DMScNicolai Lohse, MD, PhD, DMScFrom Copenhagen University, Copenhagen, Denmark. and Niels Obel, MD, DMScFrom Copenhagen University, Copenhagen, Denmark.Author, Article, and Disclosure Informationhttps://doi.org/10.7326/L16-0091 SectionsAboutFull TextPDF ToolsAdd to favoritesDownload CitationsTrack CitationsPermissions ShareFacebookTwitterLinkedInRedditEmail Background: In 2007, we and others reported encouraging survival estimates for persons receiving HIV care in the Danish HIV Cohort Study (1). We estimated that 25-year-old persons with HIV infection not co-infected with hepatitis C virus would survive to a median age of 63.9 years. Despite these encouraging findings, median survival was still 12.2 years short of that observed in a sex- and age-matched sample of persons from the general population.Objective: To update the analyses we reported in 2007.Methods and Findings: We estimated survival for persons receiving HIV care up to 2015 using the same methods that we ...References1. Lohse N, Hansen AB, Pedersen G, Kronborg G, Gerstoft J, Sørensen HT, et al. Survival of persons with and without HIV infection in Denmark, 1995-2005. Ann Intern Med. 2007;146:87-95. [PMID: 17227932] LinkGoogle Scholar2. Nakagawa F, May M, Phillips A. Life expectancy living with HIV: recent estimates and future implications. Curr Opin Infect Dis. 2013;26:17-25. [PMID: 23221765] doi:10.1097/QCO.0b013e32835ba6b1 CrossrefMedlineGoogle Scholar3. Sabin CA. Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy? BMC Med. 2013;11:251. [PMID: 24283830] doi:10.1186/1741-7015-11-251 CrossrefMedlineGoogle Scholar4. Nsanzimana S, Remera E, Kanters S, Chan K, Forrest JI, Ford N, et al. Life expectancy among HIV-positive patients in Rwanda: a retrospective observational cohort study. Lancet Glob Health. 2015;3:e169-77. [PMID: 25701995] doi:10.1016/S2214-109X(14)70364-X CrossrefMedlineGoogle Scholar5. Helleberg M, Afzal S, Kronborg G, Larsen CS, Pedersen G, Pedersen C, et al. Mortality attributable to smoking among HIV-1-infected individuals: a nationwide, population-based cohort study. Clin Infect Dis. 2013;56:727-34. [PMID: 23254417] doi:10.1093/cid/cis933 CrossrefMedlineGoogle Scholar Author, Article, and Disclosure InformationAffiliations: From Copenhagen University, Copenhagen, Denmark.Disclosures: Disclosures can be viewed at www.acponline.org/authors/icmje/ConflictOfInterestForms.do?msNum=L16-0091. PreviousarticleNextarticle Advertisement FiguresReferencesRelatedDetails Metrics Cited byFactors associated with health-related quality of life in people living with HIV in NorwaySARS-CoV-2-Specific T Cell Responses in Immunocompromised Individuals with Cancer, HIV or Solid Organ TransplantsVirological efficacy of switch to DTG plus 3TC in a retrospective observational cohort of suppressed HIV-1 patients with or without past M184V: the LAMRES studyPeer support in an outpatient clinic for people living with human immunodeficiency virus: a qualitative study of service users' experiences"They make a difference": a qualitative study of providers' experiences of peer support in outpatient clinics for people living with HIVCost of non‐communicable diseases in people living with HIV in the Central Denmark RegionClinical characteristics and outcomes of newly diagnosed patients with HIV ‐associated aggressive B‐cell NHL in ChinaHIV-related stigma among healthcare providers working within infectious diseases and gynecology and obstetrics at a large teaching hospital in DenmarkFewer neurocognitive deficits and less brain atrophy by third ventricle measurement in PLWH treated with modern ART: A prospective analysisNeurosurgery's Impact on Neuro-Oncology—"Can We Do Better?"—Lessons Learned Over 50 YearsLongitudinal analysis of HIV outcomes for persons living with HIV in non-urban areas in southern Alberta, CanadaProgression of cardiac structure and function in people with human immunodeficiency virusLack of a Clinically Meaningful Drug Interaction Between the HIV‐1 Antiretroviral Agents Islatravir, Dolutegravir, and Tenofovir Disoproxil FumarateCervical cancer prevention and control in women living with human immunodeficiency virusDiferencias epidemiológicas y de mortalidad entre hombres y mujeres con infección por VIH en la cohorte CoRIS entre los años 2004 y 2014Differences in epidemiology and mortality between men and women with HIV infection in the CoRIS cohort from 2004 to 2014Do women with HIV/AIDS on anti-retroviral therapy have a lower incidence of symptoms associated with menstrual dysfunction?Different Trends of Distinct Time Points of AIDS Events Following HIV Diagnosis in Various At-risk Populations: A Retrospective Nationwide Cohort Study in TaiwanLife expectancy of HIV-infected patients followed at the largest hospital in Guinea-Bissau is one-fourth of life expectancy of the background populationAlzheimer's-Like Pathology at the Crossroads of HIV-Associated Neurological DisordersThe burden of non‐communicable diseases and mortality in people living with HIV (PLHIV) in the pre‐, early‐ and late‐HAART eraHIV Infection: Time from Diagnosis to Initiation of Antiretroviral Therapy in Portugal, a Multicentric StudySynthesis of Rovafovir Etalafenamide (Part I): Active Pharmaceutical Ingredient Process Development, Scale-Up, and Impurity Control StrategyPhysical and mental health in HIV-infected patients with virological success and long-term exposure to antiretroviral therapyThe role of multimodality imaging in HIV-related heart diseaseMechanisms and therapeutic potential of interactions between human amyloids and virusesHigher plasma drug levels in elderly people living with HIV treated with darunavirNano Co-Crystal Embedded Stimuli-Responsive Hydrogels: A Potential Approach to Treat HIV/AIDSPrevalence of low bone mineral density among people living with HIVAmino-terminal Pro-B-Type Natriuretic Peptide Among Patients Living With Both Human Immunodeficiency Virus and Heart FailureRole of Inflammasomes in HIV-1 and Drug Abuse Mediated NeuroinflammagingTwelve-Year Trend in the Prevalence of High-Risk Human Papillomavirus Infection Among Rwandan Women Living With HIVHIV Lymphoma and Burkitts LymphomaHIV treatment and prevention 2019mHealth Interventions to Promote Anti-Retroviral Adherence in HIV: Narrative ReviewContemporary Lifestyle Modification Interventions to Improve Metabolic Comorbidities in HIVPersistence of cervical high-risk human papillomavirus in women living with HIV in Denmark – the SHADEThe ART of Antiretroviral Therapy in Critically Ill Patients With HIVOptimizing treatment of HIV-associated lymphomaHeart Failure among People with HIV: Evolving Risks, Mechanisms, and Preventive ConsiderationsDoes HIV infection contribute to increased beta-amyloid synthesis and plaque formation leading to neurodegeneration and Alzheimer's disease?Heart failure and adverse heart failure outcomes among persons living with HIV in a US tertiary medical centerTwo-drug vs . three-drug combinations for HIV-1: Do we have enough data to make the switch?Analysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adultsAnalysis of the costs and cost-effectiveness of the guidelines recommended by the 2018 GESIDA/Spanish National AIDS Plan for initial antiretroviral therapy in HIV-infected adultsLong-Acting HIV Drugs for Treatment and PreventionAssociation between smoking status assessed with plasma-cotinine and inflammatory and endothelial biomarkers in HIV-positive and HIV-negative individualsSleep Apnea and Heart Failure With a Reduced Ejection Fraction Among Persons Living With Human Immunodeficiency VirusExpert consensus statement on the science of HIV in the context of criminal lawProtease Inhibitors and Cardiovascular Outcomes in Patients With HIV and Heart FailureEditorialCosts and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsCosts and cost-efficacy analysis of the 2017 GESIDA/Spanish National AIDS Plan recommended guidelines for initial antiretroviral therapy in HIV-infected adultsManagement of Antiretrovirals in Critically Ill PatientsDoes HIV Really Augment the Frequency or Mortality Risk of Increased Pulmonary Artery Systolic Pressures?Cardiovascular disease risk among women living with HIV in North America and EuropeHIV-1-associated neurocognitive disorder: epidemiology, pathogenesis, diagnosis, and treatmentCervical cancer control in HIV-infected women: Past, present and futureCardiovascular Disease Imaging in HIVHIV-EnzephalopathieII. Pitfalls Pertaining to Management of Dyslipidemia in Daily Medical Practice 15 November 2016Volume 165, Issue 10Page: 749-750KeywordsCohort studiesDisclosureDrugsHIVHIV infectionsHepatitis C virusInterquartile rangeLife expectancyMedical risk factors ePublished: 15 November 2016 Issue Published: 15 November 2016 Copyright & PermissionsCopyright © 2016 by American College of Physicians. All Rights Reserved.PDF downloadLoading ...